Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer Ruchika Sharma25 May 2025 3:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Breast cancer drug shows potential for treatment of rare appendix cancer, suggests study Dr. Kamal Kant Kohli3 Nov 2024 9:15 PM ISTResearchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer has the potential to be an...
Roche Inavolisib gets USFDA priority review for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation Ruchika Sharma29 May 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application and granted Priority...
Roche gets USFDA Breakthrough Therapy Designation for Inavolisib for breast cancer with mutation Ruchika Sharma21 May 2024 2:30 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an...
CDSCO Panel grants Pfizer's Protocol Amendment for Anti-cancer Drug Palbociclib study Dr. Divya Colin16 March 2024 4:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Giredestrant for Breast Cancer Dr. Divya Colin7 Jan 2024 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Justification and Rational: CDSCO Panel tells Pfizer on protocol amendment proposal for Palbociclib Dr. Divya Colin20 Dec 2023 6:25 PM ISTNew Delhi: In response to the proposal presented by the drug major Pfizer for the protocol amendment, the Subject Expert Committee (SEC) functional...
From Cancer Medicines to Insulins: AIIMS Expands Free Medication List Kajal Rajput20 Oct 2023 1:40 PM ISTAIIMS Delhi has expanded its list of free medications by adding 63 more drugs, bringing the total to 359. This move aims to enhance healthcare...
Zydus Lifesciences gets tentative nod from USFDA for Palbociclib tablets Medical Dialogues Bureau1 July 2023 3:14 PM ISTNew Delhi: Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Palbociclib tablets,...
Palbociclib Sale: Delhi HC orders firm to pay Rs 2 crore damages to Pfizer Ruchika Sharma6 Feb 2023 1:15 PM ISTAs the firm was found continuing to sell Palbociclib, the court held the defendants guilty of wilful disobedience of its order and committing contempt...
Alkem launches novel breast cancer treatment drug Palbociclib under brand name Palbo Dr. Nandita Mohan18 Jan 2023 11:15 AM ISTPalbo comes in capsule form in multiple dose strengths with varied pricing ranges, including 125mg at INR 6125/- for 21 capsules, 100mg at Rs. 6062/-,...
Dr Reddy's Labs acquires trademark rights of breast cancer drug from Pfizer Ruchika Sharma16 Jan 2023 11:00 AM ISTThe in-house product will be retailed in the Indian market at a reduction of 85% from the current MRP to increase affordability and access to...
